1. Volume 74, Issue 5, Pages 623-630 (November 2018)
A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome 
Philip C. Bosch 
European Urology 
Volume 74, Issue 5, Pages (November 2018)
DOI: /j.eururo
Copyright © 2018 European Association of Urology Terms and Conditions

2. Fig. 1 Study design and patient allocation.
GRA=Global Response Assessment; ICPI=Interstitial Cystitis Problem Index; ICSI=Interstitial Cystitis Symptom Index; SQ=subcutaneous.
European Urology  , DOI: ( /j.eururo )
Copyright © 2018 European Association of Urology Terms and Conditions

3. Fig. 2
Change from baseline in secondary outcome measures comparing certolizumab pegol with placebo.
ICPI=Interstitial Cystitis Problem Index; ICSI=Interstitial Cystitis Symptom Index.
European Urology  , DOI: ( /j.eururo )
Copyright © 2018 European Association of Urology Terms and Conditions